Literature DB >> 28337837

Sulfated hyaluronan attenuates inflammatory signaling pathways in macrophages involving induction of antioxidants.

Florent Jouy1, Nadine Lohmann2, Elke Wandel2, Gloria Ruiz-Gómez3, M Teresa Pisabarro3, Annette G Beck-Sickinger4, Matthias Schnabelrauch5, Stephanie Möller5, Jan C Simon2, Stefan Kalkhof1,6, Martin von Bergen1,7,8, Sandra Franz2.   

Abstract

It is well recognized that high molecular weight hyaluronan (H-HA) exerts potent anti-inflammatory effects while its fragmentation into low molecular weight HA (L-HA) is discussed to promote inflammation. Chemical modification of HA with sulfate groups has been shown to foster its anti-inflammatory activity which seems to be maintained in sulfated low molecular weight HA derivatives (sL-HA). However, the molecular mechanisms by which sL-HA produces its anti-inflammatory activity are not understood. In this study, we used global quantitative proteomics combined with targeted analysis of key proteins to characterize the effect of sL-HA on fully differentiated human inflammatory macrophages (iMФ). Culture of iMФ with sL-HA did not affect cell viability but resulted in a reduced pro-inflammatory cytokine response of iMФ after activation indicating a profound counter-regulation of their initial inflammatory phenotype. Rapid internalization of sL-HA involving CD44 and scavenger receptors was observed. Furthermore, an upregulation of the antioxidants SOD2 and SOD3 was found while no oxidative stress was induced. Consequently, activity of transcription factors for inflammatory gene expression was downregulated in iMФ with sL-HA after activation whereas anti-inflammatory proteins were induced. This study proves anti-inflammatory properties of sL-HA and provides information on its regulatory mode of action on iMФ.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Anti-inflammation; Antioxidants; Glycosaminoglycans; Macrophages; Sulfated hyaluronan

Year:  2017        PMID: 28337837     DOI: 10.1002/pmic.201700082

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

Review 1.  Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease.

Authors:  Robin Caird; Michael Williamson; Azeez Yusuf; Debananda Gogoi; Michelle Casey; Noel G McElvaney; Emer P Reeves
Journal:  Int J Mol Sci       Date:  2022-06-08       Impact factor: 6.208

2.  Sulfated Hyaluronan Binds to Heparanase and Blocks Its Enzymatic and Cellular Actions in Carcinoma Cells.

Authors:  Jia Shi; Riku Kanoya; Yurina Tani; Sodai Ishikawa; Rino Maeda; Sana Suzuki; Fumiya Kawanami; Naoko Miyagawa; Katsuhiko Takahashi; Teruaki Oku; Ami Yamamoto; Kaori Fukuzawa; Motowo Nakajima; Tatsuro Irimura; Nobuaki Higashi
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

3.  Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.

Authors:  Johannes R Schmidt; Elke Rücker-Braun; Katharina Heidrich; Malte von Bonin; Friedrich Stölzel; Christian Thiede; Jan M Middeke; Gerhard Ehninger; Martin Bornhäuser; Johannes Schetelig; Kristin Schubert; Martin von Bergen; Falk Heidenreich
Journal:  Proteomes       Date:  2018-02-12

4.  Glycosaminoglycans influence enzyme activity of MMP2 and MMP2/TIMP3 complex formation - Insights at cellular and molecular level.

Authors:  Gloria Ruiz-Gómez; Sarah Vogel; Stephanie Möller; M Teresa Pisabarro; Ute Hempel
Journal:  Sci Rep       Date:  2019-03-20       Impact factor: 4.379

5.  Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation.

Authors:  Claudia Damaris Müller; Gloria Ruiz-Gómez; Sophie Cazzonelli; Stephanie Möller; Robert Wodtke; Reik Löser; Joanna Freyse; Jan-Niklas Dürig; Jörg Rademann; Ute Hempel; M Teresa Pisabarro; Sarah Vogel
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

Review 6.  Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease.

Authors:  Judith A Voynow; Shuo Zheng; Apparao B Kummarapurugu
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

7.  Increased pore size of scaffolds improves coating efficiency with sulfated hyaluronan and mineralization capacity of osteoblasts.

Authors:  Jan Krieghoff; Ann-Kristin Picke; Lorenz C Hofbauer; Christine Hofbauer; Juliane Salbach-Hirsch; Sandra Rother; Christiane Heinemann; Ricardo Bernhardt; Christian Kascholke; Stephanie Möller; Martina Rauner; Matthias Schnabelrauch; Vera Hintze; Dieter Scharnweber; Michaela Schulz-Siegmund; Michael C Hacker
Journal:  Biomater Res       Date:  2019-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.